Counterpoint re: "Mammography screening-sticking to the science".
نویسنده
چکیده
In the Canadian National Breast Screening Study, the hazard ratio for breast cancer–specific death was 1.47 for women with cancers detected in the prevalence screening round, 0.9 for women with cancers detected in the subsequent four screening rounds, and 1.05 for women with cancers detected in all screening rounds. Dr. Martin Yaffe claims that these figures are compelling evidence of a randomization problem. The correct interpretation is this: An excess of 142 cancers occurred in the screening arm at the end of screening period, and an excess of 106 cancers were detected at 15 years post-screening. We therefore estimate that 106 of the 142 cancers in the initial excess were attributable to overdiagnosis, and 36 were attributable to early diagnosis. That is, if the controls had undergone screening, 36 more cancers would have been detected in year 1, and 36 fewer cancers would have been detected in years 2–4 (because of early diagnosis). The deaths from those 36 cancers, if any, would be counted among the prevalent screens, thereby increasing the hazard ratio for cancers diagnosed in year 1 and decreasing the hazard ratio for cancers diagnosed in years 2–4. For that reason, the odds ratio for deaths among cases diagnosed during the prevalence screens is expected to be higher than the odds ratio among the incident screens, and the proper interpretation relies on the hazard ratio generated for years 1–5 combined. I have addressed the other issues previously.
منابع مشابه
Mammography screening: are women really giving informed consent? (Countering the counterpoint).
Dr. Alfred Berg’s counterpoint is gracious and informative. I am grateful that he reinforces the often disregarded but currently best available version of the truth: in women younger than age 50 years, screening benefits take longer to become apparent and absolute benefits are smaller compared with older women. In Dr. Berg’s words, longer means 13–20 years after randomization. My commentary foc...
متن کاملThe Impact of Information on Women’s Willingness to Pay for Mammography Screening
The Impact of Information on Women’s Willingness to Pay for Mammography Screening Shiva Rahmani1, Shirin Nosratnejad2,3,* 1Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran 2Iranian Center of Excellence in Health Services Management, Tabriz University of Medical Sciences, Tabriz, Iran 3 Tabriz Health Services Ma...
متن کاملStudy of Screening Mammography Frequency and Related Variables in Women Referring to the Mammography Center, Mousavi Hospital, Zanjan
Background: Breast cancer is the most common cancer found in women, and screening is the best way to make an early diagnosis. The aim of this study was to determine the rate of screening mammography and related variables in the mammography center of Mousavi Hospital, located in Zanjan, Iran. Methods: This was a prospective descriptive study. Study sample size was 526 women who were selected by...
متن کاملBarriers to Participation of Breast Cancer Patients’ Relatives in Mammographic Screening
Introduction: Breast cancer is the most common female cancer in the world and Iran and the leading cause of cancer death among Iranian women. One way to control this cancer is to get screened and diagnosed early. Given that screening in the general population is not possible, early detection of this cancer in high-risk women is one way to control it. Mammography is one way to diagnose breast ca...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Current oncology
دوره 22 3 شماره
صفحات -
تاریخ انتشار 2015